Byoung Ha Kim

Title: Byoung Ha Kim: Innovator in Pharmaceutical Chemistry

Introduction

Byoung Ha Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on improving the treatment options for various metabolic syndromes and related health issues.

Latest Patents

Byoung Ha Kim holds a patent for a compound titled "N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same." This patent discloses a novel dicarboxylic acid salt of N,N-dimethylimidodicarbonimidic diamide. The preparation method involves reacting N,N-dimethylimidodicarbonimidic diamide with a specific dicarboxylic acid. The resulting compound exhibits improved physical and chemical properties, including enhanced solubility, stability, non-hygroscopicity, and low toxicity. This innovation is particularly effective in preventing and treating diabetes and its complications, as well as various cancers and muscular disorders.

Career Highlights

Byoung Ha Kim is currently associated with Hanall Pharmaceutical Company, Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health, especially in the management of metabolic syndromes and related diseases.

Collaborations

Throughout his career, Byoung Ha Kim has collaborated with notable colleagues, including Sung Wuk Kim and Sung Soo Jun. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Byoung Ha Kim's innovative contributions to pharmaceutical chemistry highlight his commitment to improving health outcomes through scientific research. His patented work represents a significant advancement in the treatment of complex medical conditions.